Frequency Therapeutics
Woburn, US · Founded 2014 · Delaware corporation · 4 known investors
Find your way into Frequency Therapeutics
5 people in our graph share verified history with the Frequency Therapeutics team — schools, employers, funds. One of them is your warm intro.
Dereka Youngunlockedknows David Lucchino · together at Frequency Therapeutics
×4knows the team · via Frequency Therapeutics
Founders & leadership
Frequency Therapeutics was founded in 2014 by David Lucchino and Christopher R. Loose.
DL
David LucchinoinCo-founderDavid Lucchino is co-founder and CEO of Frequency Therapeutics, which he built from seed stage through an IPO to NASDAQ listing. He previously founded or co-founded Semprus Biosciences and LaunchCyte, and has led fundraising efforts exceeding $285 million from venture capital and strategic investors, as well as a $545 million partnership deal with Astellas Pharma.
CR
Christopher R. LooseCo-founder
Board
RL
MK
Marc KozinBoard director
MC
TB
Timothy BarberichBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$136.3M disclosed across 3 rounds · 2017–2020
▶$42.3MraisedJul 2020 · 18 investors · BiotechnologyRule 506(b)
▶$42.3MraisedJul 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy J. BarberichDirector
- Marc A. CohenDirector
- Robert S. LangerDirector
- Dana HiltExecutive Officer
- David L. LucchinoExecutive Officer, Director
- Joel S. MarcusDirector
- Christopher R. LooseExecutive Officer
- Wendy S. ArnoldExecutive Officer
- Richard MitranoExecutive Officer
- Michael HuangDirector
- Carl P. LeBelExecutive Officer
- Offering amount
- $42.3M
- Amount sold
- $42.3M
- Sales commissions
- $2M
- Placement agents
- Cowen and Company, LLC
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$62MraisedJul 2019 · 80 investors · BiotechnologyRule 506(b)
▶$62MraisedJul 2019 · 80 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert S. LangerDirector
- Michael HuangDirector
- Richard MitranoExecutive Officer
- Carl LebelExecutive Officer
- David LucchinoExecutive Officer, Director
- Christopher R. LooseExecutive Officer
- Timothy BarberichDirector
- Joel MarcusDirector
- Marc CohenDirector
- Offering amount
- $62M
- Amount sold
- $62M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$32MraisedApr 2017 · 90 investors · BiotechnologyRule 506(b)
▶$32MraisedApr 2017 · 90 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David LucchinoExecutive Officer, Director
- Christopher R. LooseExecutive Officer
- Marc KozinDirector
- Robert LangerDirector
- Marc CohenDirector
- Timothy BarberichDirector
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Frequency Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who founded Frequency Therapeutics?
- Frequency Therapeutics was founded by David Lucchino, Christopher R. Loose in 2014.
- Who are Frequency Therapeutics's investors?
- Frequency Therapeutics's investors include venBio Partners, Alexandria, Axil Capital, Kendall Capital Partners.
- How much funding has Frequency Therapeutics raised?
- Frequency Therapeutics has disclosed $136.3M raised across 3 rounds.
- Where is Frequency Therapeutics headquartered?
- Frequency Therapeutics is headquartered in Woburn, US.